Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Hypoacusis
ADR ID BADD_A04745
ADR Hierarchy
04      Ear and labyrinth disorders
04.02      Hearing disorders
04.02.01      Hearing losses
04.02.01.006      Hypoacusis
Description A general term for the complete or partial loss of the ability to hear from one or both ears. [MeSH]
MedDRA Code 10048865
MeSH ID D034381
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Auditory hypoacuity | Hearing decreased | Hearing impaired | Hearing reduced | Hypoacuity auditory | Muffled hearing in both ears | Worsening of auditory acuity | Hearing impairment aggravated | Hypoacusis | Hypoacusis unilateral | Hard of hearing | Partial hearing loss | Hearing Loss | Loss, Hearing | Hypoacuses | Hearing Impairment
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02277Triazolam--
BADD_D02329Valproic acid0.000949%
BADD_D02331Valsartan0.000381%
BADD_D02332Vancomycin--
BADD_D02333Vancomycin hydrochloride--
BADD_D02336Vardenafil hydrochloride--
BADD_D02337Varenicline0.002005%
BADD_D02345Venetoclax0.000660%
BADD_D02346Venlafaxine0.000119%
BADD_D02352Verteporfin--
BADD_D02363Vinorelbine--
BADD_D02364Vinorelbine tartrate--
BADD_D02365Vismodegib0.000302%
BADD_D02367Voltaren--
BADD_D02369Voriconazole--
BADD_D02375Water--
BADD_D02378Zalcitabine--
BADD_D02383Zidovudine--
BADD_D02392Zoledronic acid--
BADD_D02412Octreotide0.000373%
BADD_D02443Tiotropium0.001035%
BADD_D02453Midostaurin0.000246%
BADD_D02464Fingolimod0.006510%
BADD_D02465Aclidinium0.002951%
BADD_D02473Sodium chloride0.000362%
BADD_D02509Brigatinib0.000302%
BADD_D02539Calcium0.000783%
BADD_D02552Encorafenib0.000381%
BADD_D02631Phenylbutazone--
The 10th Page    First    Pre   10    Total 10 Pages